Company snapshot
Market Cap
$5B
Mid-cap2020 — today
10-Year Price
-28%
2020 — today
52-Week Range
$13.13$19.57
Current $18.70· 86%
Featured in rankings
Most Undervalued Healthcare StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Growth StocksBest GARP Stocks (Growth at a Reasonable Price)GARP Universe
Rankings recomputed after each US market close — see where SHC stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | 8.8 | — |
| ZTSZoetis Inc. | 13.0 | 2.7% |
| CNCCentene Corporation | 23.5 | — |
| ALCAlcon Inc. | 54.7 | 0.5% |
| RVMDRevolution Medicines, Inc. | -21.5 | — |
| ONCBeOne Medicines Ltd. | 5.1 | — |
| IDXXIDEXX Laboratories, Inc. | 40.8 | — |
| TEVATeva Pharmaceutical Industries Limited | 69.1 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
32.7
Below average
Below the 10-year average
Sector median 25.2above sector
P/B ratio
8.1
Below average
Below the 10-year average
Sector median 2.2above sector
EV / EBITDA
13.7
Below average
Below the 10-year average
Sector median 15.7below sector
PEG ratio
0.9
Near historic high
Near historic highs — last 10 years
Sector median 1.8below sector
FCF Yield
2.1%
Around average
Around the 10-year average
Sector median -12.6%above sector